Donneurs de tissus : Questions médicales fréquentes
Nom anglais: Tissue Donors
Descriptor UI:D014019
Tree Number:M01.898
Termes MeSH sélectionnés :
Logistic Models
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Donneurs de tissus : Questions médicales les plus fréquentes",
"headline": "Donneurs de tissus : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Donneurs de tissus : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-09",
"dateModified": "2025-04-04",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Donneurs de tissus"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Personnes",
"url": "https://questionsmedicales.fr/mesh/D009272",
"about": {
"@type": "MedicalCondition",
"name": "Personnes",
"code": {
"@type": "MedicalCode",
"code": "D009272",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "M01"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Donneurs de sang",
"alternateName": "Blood Donors",
"url": "https://questionsmedicales.fr/mesh/D001782",
"about": {
"@type": "MedicalCondition",
"name": "Donneurs de sang",
"code": {
"@type": "MedicalCode",
"code": "D001782",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "M01.898.313"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Donneur vivant",
"alternateName": "Living Donors",
"url": "https://questionsmedicales.fr/mesh/D019520",
"about": {
"@type": "MedicalCondition",
"name": "Donneur vivant",
"code": {
"@type": "MedicalCode",
"code": "D019520",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "M01.898.656"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Donneurs non apparentés",
"alternateName": "Unrelated Donors",
"url": "https://questionsmedicales.fr/mesh/D061349",
"about": {
"@type": "MedicalCondition",
"name": "Donneurs non apparentés",
"code": {
"@type": "MedicalCode",
"code": "D061349",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "M01.898.828"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Donneurs de tissus",
"alternateName": "Tissue Donors",
"code": {
"@type": "MedicalCode",
"code": "D014019",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Melissa A Greenwald",
"url": "https://questionsmedicales.fr/author/Melissa%20A%20Greenwald",
"affiliation": {
"@type": "Organization",
"name": "American Association of Tissue Banks, McLean, Virginia, USA."
}
},
{
"@type": "Person",
"name": "Sujata Das",
"url": "https://questionsmedicales.fr/author/Sujata%20Das",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Claus Cursiefen",
"url": "https://questionsmedicales.fr/author/Claus%20Cursiefen",
"affiliation": {
"@type": "Organization",
"name": "Zentrum für Augenheilkunde, Uniklinik Köln."
}
},
{
"@type": "Person",
"name": "Namrata Sharma",
"url": "https://questionsmedicales.fr/author/Namrata%20Sharma",
"affiliation": {
"@type": "Organization",
"name": "Cornea, Cataract and Refractive Services, Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India."
}
},
{
"@type": "Person",
"name": "Sabine Salla",
"url": "https://questionsmedicales.fr/author/Sabine%20Salla",
"affiliation": {
"@type": "Organization",
"name": "Department of Ophthalmology, RWTH Aachen University, Pauwelsstr. 30, 52074 Aachen, Germany."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Design and Implementation of Smart Community Big Data Dynamic Analysis Model Based on Logistic Regression Model.",
"datePublished": "2022-06-22",
"url": "https://questionsmedicales.fr/article/35785068",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1155/2022/4038084"
}
},
{
"@type": "ScholarlyArticle",
"name": "Prediction of protein aggregation propensity employing SqFt-based logistic regression model.",
"datePublished": "2023-07-27",
"url": "https://questionsmedicales.fr/article/37516225",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ijbiomac.2023.126036"
}
},
{
"@type": "ScholarlyArticle",
"name": "Multiple logistic regression model to predict bile leak associated with subtotal cholecystectomy.",
"datePublished": "2023-04-04",
"url": "https://questionsmedicales.fr/article/37016083",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00464-023-10049-2"
}
},
{
"@type": "ScholarlyArticle",
"name": "A noble extended stochastic logistic model for cell proliferation with density-dependent parameters.",
"datePublished": "2022-05-30",
"url": "https://questionsmedicales.fr/article/35637247",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-022-12719-y"
}
},
{
"@type": "ScholarlyArticle",
"name": "Combining proteomic markers to construct a logistic regression model for polycystic ovary syndrome.",
"datePublished": "2023-10-03",
"url": "https://questionsmedicales.fr/article/37854181",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fendo.2023.1227252"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Personnes",
"item": "https://questionsmedicales.fr/mesh/D009272"
},
{
"@type": "ListItem",
"position": 3,
"name": "Donneurs de tissus",
"item": "https://questionsmedicales.fr/mesh/D014019"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Donneurs de tissus - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Donneurs de tissus",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-18",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Donneurs de tissus",
"description": "Comment évaluer la compatibilité des tissus ?\nQuels tests sont effectués sur les donneurs ?\nQuand un donneur est-il considéré comme inéligible ?\nQuelles sont les indications pour le don de tissus ?\nComment se déroule l'évaluation médicale d'un donneur ?",
"url": "https://questionsmedicales.fr/mesh/D014019?mesh_terms=Logistic+Models&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Donneurs de tissus",
"description": "Quels symptômes peuvent indiquer un problème de don ?\nY a-t-il des effets secondaires après le don de tissus ?\nComment reconnaître une infection post-don ?\nQuels signes d'alerte après un don de tissus ?\nLes donneurs ressentent-ils des douleurs après le don ?",
"url": "https://questionsmedicales.fr/mesh/D014019?mesh_terms=Logistic+Models&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Donneurs de tissus",
"description": "Comment prévenir les infections après un don ?\nQuelles précautions prendre avant de donner des tissus ?\nComment se préparer à un don de tissus ?\nY a-t-il des vaccinations recommandées pour les donneurs ?\nComment éviter les complications après le don ?",
"url": "https://questionsmedicales.fr/mesh/D014019?mesh_terms=Logistic+Models&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Donneurs de tissus",
"description": "Quels traitements sont disponibles pour les donneurs ?\nComment gérer la douleur après le don ?\nY a-t-il un suivi médical après le don ?\nQuels soins sont nécessaires après un don de tissus ?\nLes donneurs ont-ils besoin de réhabilitation ?",
"url": "https://questionsmedicales.fr/mesh/D014019?mesh_terms=Logistic+Models&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Donneurs de tissus",
"description": "Quelles sont les complications possibles du don de tissus ?\nComment reconnaître une complication après le don ?\nLes complications sont-elles fréquentes ?\nQue faire en cas de complication après le don ?\nLes complications peuvent-elles affecter la santé future ?",
"url": "https://questionsmedicales.fr/mesh/D014019?mesh_terms=Logistic+Models&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Donneurs de tissus",
"description": "Quels sont les facteurs de risque pour les donneurs ?\nComment les antécédents médicaux influencent-ils le don ?\nLes infections antérieures affectent-elles le don ?\nQuels comportements augmentent les risques pour les donneurs ?\nLes donneurs âgés ont-ils plus de risques ?",
"url": "https://questionsmedicales.fr/mesh/D014019?mesh_terms=Logistic+Models&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment évaluer la compatibilité des tissus ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "La compatibilité est évaluée par des tests de typage tissulaire et de groupes sanguins."
}
},
{
"@type": "Question",
"name": "Quels tests sont effectués sur les donneurs ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins pour les infections et des évaluations de santé générale sont réalisés."
}
},
{
"@type": "Question",
"name": "Quand un donneur est-il considéré comme inéligible ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un donneur est inéligible s'il a des infections transmissibles ou des maladies graves."
}
},
{
"@type": "Question",
"name": "Quelles sont les indications pour le don de tissus ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les indications incluent les greffes de cornée, de peau, et de tissus osseux."
}
},
{
"@type": "Question",
"name": "Comment se déroule l'évaluation médicale d'un donneur ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'évaluation comprend un examen physique et un historique médical détaillé."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer un problème de don ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme la fièvre, la fatigue ou des douleurs peuvent alerter."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets secondaires après le don de tissus ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des effets secondaires peuvent inclure des douleurs au site de prélèvement ou des infections."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une infection post-don ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une infection peut se manifester par rougeur, chaleur, ou écoulement au site de prélèvement."
}
},
{
"@type": "Question",
"name": "Quels signes d'alerte après un don de tissus ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme une douleur intense ou une fièvre élevée nécessitent une consultation médicale."
}
},
{
"@type": "Question",
"name": "Les donneurs ressentent-ils des douleurs après le don ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une douleur légère à modérée est courante, mais elle doit être surveillée."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections après un don ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est essentiel de garder le site propre et de suivre les instructions médicales."
}
},
{
"@type": "Question",
"name": "Quelles précautions prendre avant de donner des tissus ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Évitez les médicaments anticoagulants et informez le médecin de votre état de santé."
}
},
{
"@type": "Question",
"name": "Comment se préparer à un don de tissus ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Suivez les recommandations médicales, hydratez-vous et reposez-vous avant le don."
}
},
{
"@type": "Question",
"name": "Y a-t-il des vaccinations recommandées pour les donneurs ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des vaccinations contre certaines infections peuvent être recommandées avant le don."
}
},
{
"@type": "Question",
"name": "Comment éviter les complications après le don ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Suivez les instructions médicales et signalez tout symptôme inhabituel rapidement."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les donneurs ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des analgésiques et des soins pour le site de prélèvement."
}
},
{
"@type": "Question",
"name": "Comment gérer la douleur après le don ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La douleur peut être gérée avec des médicaments prescrits et des soins appropriés."
}
},
{
"@type": "Question",
"name": "Y a-t-il un suivi médical après le don ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un suivi médical est recommandé pour surveiller la récupération et prévenir les complications."
}
},
{
"@type": "Question",
"name": "Quels soins sont nécessaires après un don de tissus ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des soins incluent le nettoyage du site et l'observation des signes d'infection."
}
},
{
"@type": "Question",
"name": "Les donneurs ont-ils besoin de réhabilitation ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "La réhabilitation est rarement nécessaire, mais peut être recommandée en cas de complications."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles du don de tissus ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent inclure des infections, des saignements ou des réactions allergiques."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une complication après le don ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme une douleur accrue, une rougeur ou un gonflement peuvent indiquer une complication."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles fréquentes ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications sont rares mais peuvent survenir, nécessitant une attention médicale."
}
},
{
"@type": "Question",
"name": "Que faire en cas de complication après le don ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Consultez immédiatement un professionnel de santé si vous suspectez une complication."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles affecter la santé future ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent avoir des effets à long terme, mais cela reste rare."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les donneurs ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents médicaux, des infections et des comportements à risque."
}
},
{
"@type": "Question",
"name": "Comment les antécédents médicaux influencent-ils le don ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des antécédents de maladies graves peuvent rendre un individu inéligible au don."
}
},
{
"@type": "Question",
"name": "Les infections antérieures affectent-elles le don ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines infections antérieures peuvent compromettre la sécurité du don."
}
},
{
"@type": "Question",
"name": "Quels comportements augmentent les risques pour les donneurs ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des comportements comme l'usage de drogues ou des rapports sexuels non protégés augmentent les risques."
}
},
{
"@type": "Question",
"name": "Les donneurs âgés ont-ils plus de risques ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge avancé peut être un facteur de risque, mais chaque cas est évalué individuellement."
}
}
]
}
]
}
With the economic development, smart communities have been widely studied and applied. However, the system in this field is not perfect, and there are still a series of problems, such as high construc...
Here we present a novel machine-learning approach to predict protein aggregation propensity (PAP) which is a key factor in the formation of amyloid fibrils based on logistic regression (LR). Amyloid f...
There are no prediction models for bile leakage associated with subtotal cholecystectomy (STC). Therefore, this study aimed to generate a multivariable prediction model for post-STC bile leakage and e...
We analysed prospectively managed data of patients who underwent STC by a single consultant surgeon between 14 May 2013 and 21 December 2021. STC was schematised into four variants with five subvarian...
A total of 81 patients underwent the STC procedure. Twenty-eight patients (35%) developed bile leakage. Of these, 18 patients (64%) required secondary surgical intervention. Multivariable logistic reg...
Open-tract STC and acute cholecystitis are the most reliable predictors of bile leakage associated with STC. Future prospective, multicentre studies with higher statistical power are needed to generat...
Cell proliferation often experiences a density-dependent intrinsic proliferation rate (IPR) and negative feedback from growth-inhibiting molecules in culture media. The lack of flexible models with ex...
Proteomics technology has been used in various fields in recent years for the Q6 exploration of novel markers and the study of disease pathogenesis, and has become one of the most important tools for ...
In our previous study we used DIA proteomics to screen for proteins that were significant in 31 PCOS patients compared to women of normal reproductive age. In this study, we used logistic regression a...
We constructed a logistic model using these protein markers, where HIST1H4A (OR=1.037) was an independent risk factor for polycystic ovary syndrome and TREML1 (OR=0.976) were protective factors for th...
Our study is the first to use proteomic results with clinical biochemical data to construct a logistic regression model, and the model is consistent. However, our study still needs a more complete sam...
To establish the risk scoring model for HIV-negative neurosyphilis (NS) patients and to optimize the lumbar puncture strategy....
From 2016 to 2021, clinical information on 319 syphilis patients was gathered. Multivariate logistic regression was used to examine the independent risk factors in NS patients who tested negative for ...
There were statistically significant differences between HIV-negative NS and non-neurosyphilis (NNS) patients in the following factors. These included age, gender, neuropsychiatric symptoms (including...
The risk scoring model in this study can classify the risk of neurosyphilis in syphilis patients, optimize the lumbar puncture strategy to a certain extent, and provide ideas for the clinical diagnosi...
Adjustment for baseline prognostic factors in randomized clinical trials is usually performed by means of sample-based regression models. Sample-based models may be incorrect due to overfitting. To as...
We conducted a simulation study using samples drawn from a "population" in which both the treatment effect and the effect of the potential confounder were specified. The outcome variable was binary. U...
Sample-based adjustment models yielded more biased estimates of the treatment effect than adjustment models that used the true confounder effect but had similar variance, accuracy, power, and type 1 e...
Sample-based adjustment yields similar results to exact adjustment in estimating the treatment effect. Sample-based adjustment is preferable to no adjustment....
The validation of mathematical models of tumour growth is frequently hampered by the lack of sufficient experimental data, resulting in qualitative rather than quantitative studies. Recent approaches ...
The multiscale expansion of logistic growth models was performed by coupling gene expression profiles to the cell death rates. State-of-the-art Bayesian inference, likelihood maximisation and uncertai...
The results suggest that the classical single-cell population model (SCPM) was the best fit for the untreated and low-dose treatment conditions, while the multiscale model with a cell death rate symme...
Overall, the present study demonstrates that model performance can be improved by incorporating multiscale measurements of tumour growth when high-dose treatment is involved....
Multinomial logistic regression models allow one to predict the risk of a categorical outcome with > 2 categories. When developing such a model, researchers should ensure the number of participants (...
The first criterion aims to minimise the model overfitting. The second aims to minimise the difference between the observed and adjusted...
We tested the performance of the proposed criteria (i) through a simulation study and found that it resulted in the desired level of overfitting. Criterion (ii) and (iii) were natural extensions from ...
We illustrated how to implement the sample size criteria through a worked example considering the development of a multinomial risk prediction model for tumour type when presented with an ovarian mass...
This study aimed to explore the risk factors for failed treatment of carbapenem-resistant...
A total of 189 CRAB-VAP patients were included in the safety analysis set from two Grade 3 A national-level hospitals between 1 January 2022 and 31 December 2022. The risk factors for failed treatment...
Of the 189 patients, 106 (56.1%) patients were in the successful treatment group, and 83 (43.9%) patients were in the failed treatment group. The multivariate logistic model analysis showed that age (...
Age, hypoproteinemia, daily dose, medication within 14 days prior to surgical intervention, and microbial clearance are all significant risk factors for failed treatment with CRAB-VAP, with the nomogr...